top of page
NEWS
News
Search

World TB Day: advancing the fight against tuberculosis
March 24 marks World Tuberculosis Day on the anniversary of Dr. Robert Koch's groundbreaking discovery of Mycobacterium tuberculosis in 1882
EVI
6 days ago4 min read
20

VACCELERATE concludes: achievements from the first Europe’s Corona Vaccine Trial Accelerator
From establishing a strong clinical trial network to accelerating vaccine research and fostering cross-border collaboration, VACCELERATE...
EVI
Feb 72 min read
55


New clinical trial investigates safety and immune response of Invaplex AR-Detox Shigella vaccineÂ
A newly published article outlines the protocol for new phase Ia/b clinical trial for the Invaplex AR-Detox  Shigella vaccine...
EVI
Feb 52 min read
59

TRANSVAC: a pillar of vaccine development in Europe for 16 years
The European vaccine development ecosystem has been strengthened over the last 16 years, thanks to the TRANSVAC project, funded by the EC.
EVI
Jan 312 min read
29


Publication of first-in-human data of malaria vaccine candidate, R21 in Matrix-M adjuvant
Phase 1 clinical trials in the UK and Burkina Faso showed that the malaria vaccine candidate, R21 adjuvanted with Matrix-M, has an...
EVI
Jan 303 min read
117

World Neglected Tropical Diseases (NTDs) Day 2025: UNITE, ACT, ELIMINATE
Neglected Tropical Diseases (NTDs) cause immense suffering and affect an estimated 1 billion people mostly in isolated and marginalised...
EVI
Jan 302 min read
65


Now is the time to accelerate the development of second-generation malaria vaccines through investment, innovation and public-private partnerships.
At the World Vaccine Congress 2024, an EVI-organised panel discussion explored the lessons learnt from licensed malaria vaccines.
EVI
Dec 17, 20244 min read
113


Chronicles from Malawi, Africa
Understanding cultural beliefs and practices around pregnancy and vaccination Our ethnographic study in Malawi—focused on understanding...
EVI
Dec 12, 20245 min read
139


EVI Team Retreat: strengthening resilience and building unity
November 2024 Last week, the EVI team gathered in Frankfurt for a retreat designed to recharge, step away from our daily routines, and...
EVI
Nov 22, 20241 min read
170


EVI showcases progress in placental malaria research at PDP IV Annual Meeting
T he European Vaccine Initiative (EVI) proudly participated in the Product Development Partnerships (PDP) IV Annual Meeting on November...
EVI
Nov 20, 20241 min read
98


Antimicrobial Awareness Week 2024 – Educate. Advocate. Act now against superbugs!
AMR is growing on a global scale and has become a top 10 health threat that affects the effectiveness of antimicrobial medicines.
EVI
Nov 17, 20244 min read
35

PhD Researchers advancing malaria vaccine research with successful dissertation defences in MMVC project
Two PhD students, Dr. Elizabeth Kibwana and Dr. Caroline Bundi, have successfully defended their dissertations under the Multi-Stage...
EVI
Nov 8, 20242 min read
111


ShigaPlexIM: SUNSHINE trial begins testing new shigellosis vaccine
The phase Ia/b trial for the InvaplexAR-Detox/dmLT vaccine started at LUMC, in Netherlands.
EVI
Oct 15, 20242 min read
91

EVI and TBVI team up with VAC4EU
European Vaccine Initiative (EVI) and the Tuberculosis Vaccine Initiative (TBVI) are proud to announce a new partnership with VAC4EU.
EVI
Oct 9, 20241 min read
88

Naobios and European Vaccine Initiative partner up to manufacture Respiratory Syncytial Virus (RSV) challenge agent
Collaboration will support Controlled Human Infection Model studies to accelerate development of effective and affordable RSV vaccines.
EVI
Oct 8, 20243 min read
82

Preserving European Antibiotics: The Need for Sustainable R&D FundingÂ
AMR Accelerator asks for long-term investments, emphasising the need to preserve the European capacity to combat drug-resistant infections.
EVI
Sep 23, 20243 min read
39

Launch of TRANSVAC Academy for Vaccine Researchers and Developers
EVI is thrilled to announce the launch of TRANSVAC Academy, a programme providing advanced expert-led training in vaccinology.
EVI
Aug 29, 20242 min read
134


EVI-led project drives progress in reducing animal testing
The European Pharmacopoeia has announced the end of the rabbit pyrogen testing.
EVI
Jul 9, 20242 min read
130


Socio-cultural study in Malawi: an insightful first week of field work
Ethnographic study aiming at understanding local perceptions of pregnancy and vaccinations.
EVI
Jun 26, 20241 min read
53


World Clinical Trials Day: honouring medical progress & innovation
EVI supports and coordinates various clinical trials that contributes to the fight against global health diseases.
EVI
May 20, 20241 min read
31


First NOSEVAC successful face-2-face Annual Meeting in Spain
The NOSEVAC project, co-funded by the European Commission and coordinated by European Vaccine Initiative (EVI), held its first annual...
EVI
Apr 29, 20243 min read
57

World Malaria Day 2024: urgent calls for accelerated global action against malaria
Malaria poses a significant threat to public health, disproportionately affecting the most vulnerable populations. EVI strengthens the fight
EVI
Apr 25, 20242 min read
116

World Tuberculosis Day 2024– We can End TB!
World Tuberculosis Day serves as a poignant reminder to raise awareness about tuberculosis (TB). Despite the efforts and promising...
EVI
Mar 24, 20243 min read
106

TBVI announces the appointment of its new Executive Director
The TBVI Governance Board is pleased to announce the appointment of Dr. Ole F. Olesen as their new Executive Director.
EVI
Mar 1, 20243 min read
91
bottom of page